EFM-192A(人乳腺癌細(xì)胞)
CBP60364
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. General information | |
Synonyms: | EFM-192A |
Background: | established from the pleural effusion of the left side from a 46-year-old Caucasian woman with metastasizing breast adenocarcinoma in 1985; sister cell lines EFM-192B and C show differences in molecular aspects; erbB-2 gene is amplified and overexpressed |
Species: | human (Homo sapiens) |
Tissue: | breast |
Disease: | breast carcinoma |
Gender: | N/A |
Morphology: | epitheloid, adherent growing as monolayer; |
Growth Mode: | N/A |
Doubling Time: | about 9 days |
DNA Profile: | N/A Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS EFM-192A完全培養(yǎng)基,# CBP60364M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Mycoplasma: | negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
Immunology: | cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - |
Fingerprint: | same DNA profile as EFM-192B/EFM-192C using multiplex PCR of minisatellite markers |
Species: | confirmed as human with IEF of AST, NP, MDH |
Cytogenetics: | human flat-moded near-triploid karyotype with 20% polyploidy - 68(60-70)<3n>XXXX, +X, -1, -4, +9, -12, -17, -17, -18, -22, +6mar, add(1)(p22), add(1)(p?32), add(2)(q35/37), add(3)(q27/29), i(15q), add(17)(p12), dminx1 present at 38% |
Virus | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HHV-8 -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |
Comments: | For more information, please contact Cobioer (4008-750-250). |